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Dof the present study. Second, the comparison group was not
ideal and the size of the group was small. The ideal group
would be a patent LITA group that underwent dissection
of the graft. We did find 6 patients who underwent LITA dis-
section during the study period; however, that would have
been an even smaller comparison group with less value
for statistical comparison. We had 1 LITA injury among
these 6 patients who underwent LITA dissection. On the
other hand, the comparison group who had previous
CABGwithout a LITA graft will have complete myocardial
protection through antegrade cardioplegia. Thus, no coro-
nary blood flow originating distal to the aortic crossclamp
is present to wash out the cardioplegia, and good cardiople-
gia perfusion to the LAD area is provided that will not be
provided in patients with a dissected or patent LITA. That
the CK-MB levels were comparable those in this well-
protected group indicates the safety of the no-dissection
technique.CONCLUSIONS
Patients undergoing AVR after CABG in the presence of
a patent LITA are at high risk of injury. Although the com-
mon practice has been to dissect the graft and clamp to
achieve full myocardial protection, there is a danger of graft
injury during dissection. The ‘‘no-dissection’’ technique
demonstrated no increase in mortality and morbidity and
is an effective strategy using hypothermia and systemic hy-
perkalemia to counteract the cardioplegia washout effect.References
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Dr Richard Shemin (Los Angeles, Calif). Thank you very
much for a beautiful presentation and for bringing this very large
series to our forum today.
Obviously, the topic is driven by the desire, number 1, to totally
eliminate any injury to the LITA and, number 2, to try to increase
the number of minimally invasive or minimal access approaches in
the re-do CABG population who come for valve replacement. You
showed some data at the risk of injury to the LITA and you quoted
data from the 1980s and 1990s showing it was 40% to 50% and in
the modern era it may be 5%, but I personally submit that, if we
look at the re-do CABG rate in which patent LITAs are almost rou-
tine, that the rate of 5% is still an overestimate, particularly with
routine CT scanning to really know whether or not you have a tho-
racic artery that is stuck behind the sternum. I think the major con-
tributions of your paper are the size of the series, 176 patients—
there are other series in the literature, I think this is the largest
one; the fact that half these patients did have a mini-sternotomy,
which is a very important part of the series; your good outcomes,
which obviously is very important; and your ability to show that
leaving the LITA open actually allowed decent or goodmyocardial
protection.
I have a few concerns and a few questions for you.
First of all, when I review a series in which the treatment group
is 174 patients and 26 patients in the control group, I really worry
whether that is an adequate comparison and whether or not any of
the statistics between the 2 groups are really legitimate. I am not
sure you are really powered to do any comparison between the 2
groups.
You do not tell us in your presentation or in the manuscript
whether or not there was left anterior descending disease in those
26 patients and whether or not they were saphenous vein bypasses.
Can you comment on that?gery c November 2012
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DDr Kaneko.We did review all the coronary angiograms and the
computed tomography angiography before the procedure as we
mentioned. In those data, whenever we find coronary artery dis-
ease that actually went to a repair, those patients were excluded.
That was 1 of the factors why this comparison group was small.
I think your suggestion that 26 patients is a very small comparison
group is totally valid. My ideal comparison group would have been
a dissected LITA group and compare those 2 with showing a better
outcome in the no-dissection technique. However, in our institu-
tion, this technique is standard and I was only able to find 6 patients
with a dissected LITA. This was an even lower number to compare.
That is why we used this as a comparison group.
Dr Shemin. Another interesting data point that came to my at-
tention was the fact that the cardiopulmonary bypass time in the 2
groups was similar. I cannot understand that if in half the patients
you cannulated the groin went on to bypass before opening the
chest, cooled to 20 degrees, and then had to rewarm, how could
you have a similar time on bypass to a group of patients in
whom you just opened the chest? I assume that the cooling was
a routine 30 to 34 degrees, so the warming and cooling time would
obviously not be anywhere as long.
Dr Kaneko. The initiation of cardiopulmonary bypass was
completely surgeon dependent. In the data before 2002, it was
our standard practice to initiate a cardiopulmonary bypass before
doing the resternotomy. In the recent patients that at least I have
seen, we perform a sternotomy under no cardiopulmonary bypass;
however, they are cannulated and, as soon as the mediastinal dis-
section gets difficult, we started cooling, which like you said might
take time, but that will eliminate some of the time that is used in the
sternotomy time. Also, there was a slight difference, although sta-
tistically nonsignificant (5 minute shorter time), in the crossclamp
time. Our belief is that, hopefully, shorter crossclamp time is con-
tributing to that as well.
Dr Shemin. Okay. I do not quite buy it but—I mean it usually
takes 45 minutes to an hour to cool somebody to 20 degrees and
sometimes at least 1-and-a-half to twice as long to rewarm them,
so I think, again, the comparison group is somewhat detracting
from the message of the good results in your study.
The same thing with adequacy and myocardial protection: In
your manuscript, you mentioned that 22 patients, or 12.5%, re-
quired a balloon pump and 21 of those 22 were put in intraopera-
tively whereas, in the ‘‘comparison group,’’ it was only 2 patients
or 7%. Were these balloons put in for high-dose inotropes and
power failure, suggesting that maybe the myocardial protection
despite your creatine phosphokinase data were not quite as good
as you are leading us to believe?
DrKaneko.Therewere 2 patients who had a preoperative intra-
aortic balloon pump, but, yes, there are more patients who received
intra-aortic balloon pump during the case in the no-dissection
group. We do not have a good explanation for that. We were trying
to look at the inotropes along with the balloon pump to see if that
will correlate the need and possibly reflect the myocardial protec-
tion, but those values were not really available. That is one of the
weaknesses of the findings that we had.
Dr Shemin. You also mentioned in the manuscript that very of-
ten with the thoracic artery being patent that placing the sutures inThe Journal of Thoracic and Carthe annulus can sometimes be obscured particularly in the left
main coronary artery because of backflow, and you would have
to go down to flow rates between 500 and 1500. Can you say
how often that was done and for what period of time because the
stroke rate was 2.2%, which probably is quite acceptable but I
am just interested in how much low-flow perfusion was necessary
just to technically perform the suturing.
Dr Kaneko. When we placed the suction right at the coronary
ostium, unless you are putting a stitch right around that area, it is
usually pretty visible. I think the visual field is okay. We only have
to stop the pump maybe once or twice if the stitch is right at the
coronary ostium on the left side. That has been the usual case
that I have seen.
Dr Shemin. And my last question—I think everyone in the au-
dience understands hypothermia, but tell us a little bit about hyper-
kalemia, systemic hyperkalemia: To what level, how did you
achieve it, what do you do with people with renal failure? Is there
a contraindication to this technique?
Dr Kaneko. How we usually do it is we place 40 mEq of potas-
sium chloride into the pump. Our goal is above 6 but not going over
7. Usually, after 40 mEq, we were able to maintain that level. The
only time that we had to give further potassiumwas when the myo-
cardium starting moving.When there is activity, we usually add 10
to 20 mEq to control that, and that has worked pretty well. I did not
include this in the slides but we had 3 patients in the no-dissection
group who had dialysis after surgery, which equals about 2% in the
whole population. That is comparable to some of the other groups
that we have studied, so I do not think there is an increase in the
renal failure patients and, usually after the surgery at the end of
a case using ultra-filtration, potassium level is around 5. After di-
uresis by cardiopulmonary bypass, their potassium level goes to
a normal level within 24 hours.
Dr Shemin.You certainly have all that warming time to get that
potassium back down to normal.
Congratulations on a nice presentation and I thank the Western
for the opportunity to discuss this paper.
Dr John Ikonomidis (Charleston, SC). I enjoyed the presenta-
tion a lot. I have a question about the incidence of ventricular fibril-
lation in the no-dissection group.
I did not catch it in your presentation but did you record the in-
cidence of ventricular fibrillation, how long it occurred? You did
not give us any information about administration of cardioplegia
in terms of frequency. In the no-dissection group, did you give car-
dioplegia more often to try and counteract that? Also, what about
administration of antiarrhythmics in those patients? Could you
comment on those issues?
Dr Kaneko. The cardioplegia technique was surgeon prefer-
ence and about half of the patients received antegrade and half
that received antegrade and retrograde.
Ventricular fibrillation was seen especially when the patient was
hypothermic. At around 20 degrees there is usually no myocardial
activity and at around 25 or 26, when we see a fibrillation, we add
potassium to stop that activity at that time.
As far as antiarrhythmics, it is not our routine to use them in our
institutions. However, if we see a ventricular tachycardia, we do
give lidocaine in the pump and that is our standard practice, yes.diovascular Surgery c Volume 144, Number 5 1041
